Bromocriptine mesylate improves glucose tolerance and disposal in a high-fat-fed canine model
- 1 July 2020
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Endocrinology and Metabolism
- Vol. 319 (1), E133-E145
- https://doi.org/10.1152/ajpendo.00479.2019
Abstract
Bromocriptine mesylate treatment was examined in dogs fed a high fat diet (HFD) for 8 wk. After 4 wk on HFD, daily bromocriptine (Bromo; n = 6) or vehicle (CTR; n = 5) injections were administered. Oral glucose tolerance tests were performed before beginning HFD (OGTT1), 4 wk after HFD began (Bromo only), and after 7.5 wk on HFD (OGTT3). After 8 wk on HFD, clamp studies were performed, with infusion of somatostatin and intraportal replacement of insulin (4x basal) and glucagon (basal). From 0 to 90 min (P1), glucose was infused via peripheral vein to double the hepatic glucose load; and from 90 to 180 min (P2), glucose was infused via the hepatic portal vein at 4 mg.kg(-1).min(-1), with the HGL maintained at 2x basal. Bromo decreased the OGTT glucose Delta AUC(0-30) and Delta AUC(0-120) by 62 and 27%, respectively, P < 0.05 for both) without significantly altering the insulin response. Bromo dogs exhibited enhanced net hepatic glucose uptake (NHGU) compared with CTR (similar to 33 and 21% greater, P1 and P2, respectively, P < 0.05). Nonhepatic glucose uptake (non-HGU) was increased similar to 38% in Bromo in P2 (P < 0.05). Bromo vs. CTR had higher (P < 0.05) rates of glucose infusion (36 and 30%) and non-HGU (similar to 40 and 27%) than CTR during P1 and P2, respectively. In Bromo vs. CTR, hepatic 18:0/16:0 and 16:1/16:0 ratios tended to be elevated in triglycerides and were higher (P < 0.05) in phospholipids, consistent with a beneficial effect of bromocriptine on liver fat accumulation. Thus, bromocriptine treatment improved glucose disposal in a glucose-intolerant model, enhancing both NHGU and non-HGU.Funding Information
- VeroScience
- NIH-NIDDK (DK059637, DK020593)
This publication has 95 references indexed in Scilit:
- The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearanceJCI Insight, 2013
- A Dual Sugar Challenge Test for Lipogenic Sensitivity to Dietary FructoseJournal of Clinical Endocrinology & Metabolism, 2011
- Mammalian Sirt1: insights on its biological functionsCell Communication and Signaling, 2011
- Chronic consumption of a high-fat/high-fructose diet renders the liver incapable of net hepatic glucose uptakeAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Molecular Characterization of Insulin-Mediated Suppression of Hepatic Glucose Production In VivoDiabetes, 2010
- Effects of Insulin on the Metabolic Control of Hepatic Gluconeogenesis In VivoDiabetes, 2009
- Individual Stearoyl-CoA Desaturase 1 Expression Modulates Endoplasmic Reticulum Stress and Inflammation in Human Myotubes and Is Associated With Skeletal Muscle Lipid Storage and Insulin Sensitivity In VivoDiabetes, 2009
- Circadian Control of the Daily Plasma Glucose Rhythm: An Interplay of GABA and GlutamatePLOS ONE, 2008
- The effect of dietary carbohydrate on genes for fatty acid synthase and inflammatory cytokines in adipose tissues from lean and obese subjectsThe Journal of Nutritional Biochemistry, 2008
- Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and inductionExpert Opinion on Drug Metabolism & Toxicology, 2006